Akkermansia muciniphila is often called a next-generation probiotic because it represents a newer approach to probiotic discovery: instead of starting with microorganisms traditionally used in fermented foods, researchers identified a naturally occurring member of the human gut microbiome and began investigating whether specific preparations could be intentionally used to support human health.
This article is part of the AKK Knowledge Centre, our guide hub for Akkermansia, gut health and microbiome research.
Akkermansia is therefore very different from the familiar probiotic story of yoghurt cultures, lactobacilli and bifidobacteria.
But the phrase “next-generation” does not mean “better,” “stronger” or “more advanced” for every person.
It describes a developing scientific field in which researchers are exploring newly identified or precisely selected microorganisms from the human microbiome as potential probiotics or microbiome-based interventions.
Key Takeaways
- “Next-generation probiotic” is a scientific research concept, not a quality ranking.
- Akkermansia was discovered through human microbiome research rather than traditional fermented-food use.
- Its specialised relationship with the intestinal mucus layer makes it biologically different from many familiar probiotics.
- Human studies of specific Akkermansia preparations now exist, but the clinical evidence base is still developing.
- Live and pasteurised Akkermansia should not automatically be classified in the same way.
- Evidence from one strain, dose or preparation cannot automatically be applied to every commercial Akkermansia product.
- Newer does not automatically mean better than well-studied traditional probiotics.
What Does “Next-Generation Probiotic” Mean?
For decades, commercial probiotics have largely been based on microorganisms with long histories of use in fermented foods or dietary supplements.
Common examples include members of Lactobacillus and related genera, Bifidobacterium, certain Saccharomyces yeasts, and selected other microorganisms.
As microbiome sequencing technology improved, scientists became able to study thousands of microorganisms naturally living in the human intestine in much greater detail.
That opened a new question:
Could some of the microorganisms naturally associated with the human microbiome be developed into a new generation of probiotics?
This is where the idea of next-generation probiotics, often shortened to NGPs, began to grow.
The exact boundaries of the term are still evolving.
Why Does Akkermansia Fit This Concept?
1. It Was Discovered Through Gut Microbiome Research
Akkermansia muciniphila was formally described in 2004 after researchers isolated a previously unknown bacterium from a human intestinal sample.
The strain could grow using mucin as its main carbon and nitrogen source.
This is very different from many traditional probiotic strains originally selected from fermented foods.
2. It Occupies an Unusual Ecological Niche
Akkermansia is strongly associated with the mucus environment of the large intestine.
Its ability to utilise mucin places it close to the boundary between intestinal contents, gut microorganisms, mucus and intestinal epithelial cells.
This unusual ecological position helped stimulate research into its relationship with mucus biology, host-microbe interactions, gut-barrier function, microbial cross-feeding and metabolic signalling.
3. Researchers Found Interesting Associations With Human Health
Observational research reported associations involving body composition, glucose metabolism, metabolic health, intestinal barrier function, inflammatory status and microbiome composition.
But:
Association is not proof of causation.
4. Research Progressed From Animals to Human Intervention Studies
In 2019, a proof-of-concept human trial investigated supplementation with live or pasteurised A. muciniphila.
This was an important milestone because researchers were beginning to ask:
“What happens when a defined Akkermansia preparation is actually administered to humans?”
5. Human Research Is Continuing to Develop
In 2026, Nature Medicine published a randomised controlled trial involving adults with overweight or obesity.
The group receiving a specific pasteurised Akkermansia preparation regained less body weight on average during a weight-maintenance period than the placebo group.
This adds meaningful human evidence.
However, it does not mean all Akkermansia products produce weight loss, all strains work identically, live and pasteurised preparations are equivalent, or Akkermansia is universally proven as a weight-management solution.
Is Akkermansia the First Next-Generation Probiotic?
Akkermansia is certainly one of the most prominent and extensively discussed examples of a next-generation probiotic candidate.
But next-generation probiotics are a broader research category rather than a single chronological product generation.
It is more accurate to say:
Akkermansia has become one of the leading examples of next-generation probiotic research.
How Are Next-Generation Probiotics Different From Traditional Probiotics?
| Traditional Probiotics | Next-Generation Probiotic Candidates | |
|---|---|---|
| Typical origin | Food, fermentation and established microbial collections | Human microbiome and modern microbial discovery |
| Familiar examples | Lactobacilli, Bifidobacteria | Akkermansia, Faecalibacterium and others |
| History of food use | Often long | Often limited |
| Commercial experience | Extensive | Emerging |
| Research approach | Strain-specific probiotic studies | Microbiome discovery + mechanistic + clinical research |
| Manufacturing | Generally well established | May require specialised culture and processing |
| Regulatory pathway | Often clearer | Can be more complex |
| Clinical evidence | Strong for some strain-specific uses | Developing and highly organism/preparation-specific |
“Next generation” describes where the microorganism came from and how the field is developing — not its position on a quality leaderboard.
Does “Next-Generation” Mean More Scientifically Advanced?
Not automatically.
Scientific novelty and clinical usefulness are not the same thing.
Is Pasteurised Akkermansia Still a Next-Generation Probiotic?
Under the standard scientific definition, a probiotic must be alive when administered.
Pasteurised Akkermansia is no longer alive.
Therefore, although pasteurised Akkermansia comes from the same next-generation microbiome research field, it should not technically be called a probiotic under the conventional definition.
A suitably characterised preparation of inactivated microorganisms that has demonstrated a health benefit may instead fit the definition of a postbiotic.
Why Is Developing Akkermansia More Challenging?
Akkermansia is a strict anaerobe, meaning it is adapted to very low-oxygen conditions.
Developing novel gut microorganisms for commercial use can therefore involve challenges around cultivation, manufacturing, oxygen exposure, stability, storage, viable cell counts, strain identification, safety evaluation and regulatory approval.
What Must a Next-Generation Probiotic Actually Prove?
Identity
Which species and strain are being used?
Safety
Has the microorganism been adequately evaluated for the intended population and use?
Dose
What amount is actually administered?
Viability
If it is being called a probiotic, does it remain alive at an adequate amount through shelf life?
Clinical Evidence
Has the relevant preparation been tested in humans?
Study Population
Who was studied?
Outcome
What exactly changed in the study — and what did not?
What Does Current Science Still Not Know?
Researchers are still investigating:
- how different Akkermansia strains compare,
- which individuals are most likely to respond,
- whether baseline microbiome composition changes response,
- how diet influences supplementation,
- how live and pasteurised preparations differ biologically,
- whether effects persist after supplementation ends,
- what long-term use looks like,
- and how results vary across populations.
Frequently Asked Questions
What is a next-generation probiotic?
Next-generation probiotics are newly identified or newly developed microorganisms being investigated for health applications, often discovered through modern human microbiome research rather than traditional fermented-food use.
Why is Akkermansia considered next-generation?
Akkermansia was identified as a natural member of the human gut microbiome, occupies a specialised mucus-associated niche and has progressed from observational and preclinical research into human intervention studies.
Does next-generation mean better than normal probiotics?
No.
Is Akkermansia better than Lactobacillus?
There is no universal scientific basis for saying one is better.
Is pasteurised Akkermansia a probiotic?
Not under the conventional scientific definition, because probiotics must be living microorganisms.
Has Akkermansia been studied in humans?
Yes.
Does human research prove every AKK supplement works?
No.
The Bottom Line
Akkermansia muciniphila is called a next-generation probiotic candidate because it represents a new way of discovering and developing beneficial microorganisms.
But the word “next-generation” should never be mistaken for “scientifically superior.”
The most useful question is:
“What does the evidence show for this specific Akkermansia strain, preparation and use?”
Continue Learning
- Live vs pasteurised akkermansia what's the difference?
- How to evaluate clinical evidence behind a supplement
- The difference between prebiotics, probiotics and postbiotics
Selected Scientific References
- Derrien M, Vaughan EE, Plugge CM, de Vos WM. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. International Journal of Systematic and Evolutionary Microbiology. 2004.
- Depommier C, Everard A, Druart C, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nature Medicine. 2019.
- Grant ET, Monzel E, Desai MS. Navigating the duality of Akkermansia muciniphila. Nature Microbiology. 2026.
- Kern L, Tofield A, Frame J, et al. Next-generation probiotics: an outlook into current applications and future developments. Nature Reviews Microbiology. 2026.
- Mount S, Canfora EE, Jocken JW, et al. Pasteurized Akkermansia muciniphila MucT for weight loss maintenance in people with overweight and obesity: a controlled randomized trial. Nature Medicine. 2026.
Educational Disclaimer
This article is provided for general educational purposes only. It is not intended to diagnose, treat, cure or prevent any disease and does not replace advice from a qualified healthcare professional.